-
February 25, 2021 ‘One-of-a-Kind’ $10 Million Psychedelic Research Center Comes to NYUNYU will open a $10 million psychedelic research center to further its work in using...
-
February 19, 2021 Psychedelic Business News Spotlight: February 19, 2021This week in psychedelic business news: MindMed acquires a digital health company, Mindest Pharma goes...
-
February 12, 2021 Psychedelic Business News Spotlight: February 12, 2021This week in Psychedelic business news: MindMed has a new partner, Mydecine closes a funding...
-
February 11, 2021 Study: 69% of Suicidal Patients Saw ‘Significant’ Improvement With Ketamine TherapyA new study links ketamine therapy to a significant reduction in thoughts of suicide for...
-
February 5, 2021 Psychedelic Business News Spotlight: February 5, 2021This week in psychedelic business news, Super Mario's magic mushroom gets a new use, Mindset...
-
February 5, 2021 2 Massachusetts Cities Have Decriminalized Psychedelics in the Last MonthTwo Massachusetts cities have decriminalized psychedelics since the start of 2021. Cambridge and Somerville say...
-
February 3, 2021 The World’s First Psychedelic ETF Just Launched: Here’s Why That MattersThe Horizons Psychedelic ETF launched on the Canadian NEO stock exchange last month. Here's what...
-
January 29, 2021 Psychedelic Business News Spotlight: January 29, 2021This week in psychedelic business news, Psyence Group's psilocybin harvest, NeonMind's new CEO, and Mydecine...
-
January 28, 2021 Hawaii Moves to Legalize Psilocybin TreatmentHawaii may soon legalize psilocybin therapy for the treatment of a range of mental health...
-
January 22, 2021 Psychedelic Business News Spotlight: January 22, 2021This week in psychedelic industry news: the first psychedelic stock index, new products, mergers, and...
